This Article Free upon publication Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Creager, M. A. Articles by Rocha-Singh, K. J. Search for Related Content PubMed Articles by Creager, M. A. Articles by Rocha-Singh, K. J. Related Collections Other arteriosclerosis Peripheral vascular disease AHA Statements and Guidelines

(Circulation. 2008;118:2811-2825.)
© 2008 American Heart Association, Inc.

AHA Conference Proceedings

Atherosclerotic Peripheral Vascular Disease Symposium II

Executive Summary

Mark A. Creager, MD, FAHA, Conference Chair; Christopher J. White, MD, FAHA, Conference Cochair; William R. Hiatt, MD; Michael H. Criqui, MD, FAHA; Shellie C. Josephs, MD; Mark J. Alberts, MD, FAHA; William H. Pearce, MD; Bruce H. Gray, DO; Krishna J. Rocha-Singh, MD

Key Words: AHA Conference Proceedings • aneurysm • peripheral vascular disease • carotid stenosis • renal stenosis

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
The Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group was commissioned by the American Heart Association (AHA) to provide a forum to address important and emerging issues in this multidisciplinary area of clinical science. The working group was a primary outgrowth of the AHA Atherosclerotic Vascular Disease Conference held in Boston, Mass, in July 2002. It was created in recognition of the fact that atherosclerosis is a systemic disease with important sequelae in many regional circulations in addition to the heart, including the brain, kidneys, mesentery, and limbs. Its mission is to provide a forum for the multiple disciplines engaged in research, evaluation, and management of patients with noncoronary atherosclerosis. The goals of the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group are to develop a strategy to increase awareness of atherosclerotic vascular disease, identify important gap areas in knowledge that require further clinical investigation, and develop programs that will facilitate prevention and treatment of peripheral atherosclerotic diseases.

Developments in research and technology that are relevant to atherosclerotic vascular disease are emerging rapidly. As a result, greater opportunities to translate science to clinical practice are available. The American College of Cardiology/AHA practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) provide many evidenced-based recommendations for diagnosing and treating patients with atherosclerotic vascular diseases.¹ Nevertheless, in some areas, the evidence has not matured sufficiently for definitive guidelines. Some of these areas have engendered considerable controversy among practitioners. Among these are the efficacy and outcome . . . [Full Text of this Article]

This article has been cited by other articles:

				S. R. Dixon, C. L. Grines, and W. W. O'Neill The year in interventional cardiology. J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2080 - 2097. [Full Text] [PDF]